無料プレビュー

Teva Pharmaceutical Industries Limited (TEVA) · New York Stock Exchange

プロフィール

Teva Pharmaceutical Industries is a biopharmaceutical company developing, manufacturing, and marketing generic medicines, biosimilar medicines, innovative medicines (primarily in CNS, respiratory, and oncology), over-the-counter products, active pharmaceutical ingredients, and contract manufacturing services. Key innovative products include AUSTEDO and AUSTEDO XR for movement disorders, AJOVY for migraine prevention, COPAXONE for multiple sclerosis, and biosimilars such as TRUXIMA and HERZUMA. The company operates across three geographic segments: United States, Europe, and International Marke

主要指標

株価: $39.25 (+0.18%)
時価総額: 457億ドル
PER（今期予想）: 19.3
PBR: 5.8
配当利回り: —
52週レンジ: $18.83 – $40.79
業種: Healthcare / Drug Manufacturers - Specialty & Generic
上場: New York Stock Exchange
構成銘柄: —

比較会社: TAK Takeda Pharmaceutical Company Limited、HLN Haleon plc、ZTS Zoetis Inc.、VTRS Viatris Inc.、ITCI Intra-Cellular Therapies, Inc.、CTLT Catalent, Inc.、ELAN Elanco Animal Health Incorporated、RDY Dr. Reddy's Laboratories Limited

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-03 · 更新: 2026-10-09